RxDoctor Payments Data

Amna Yaqub

Infectious Disease · Flemington, NJNPI 1497052286

Payments from drug & device makers

What this record shows

That places this record below the midpoint for infectious disease clinicians in NJ, where the typical reported total is $414.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$1,439,919in research payments, 2019–2025

Across 51 payments — averaging $28,234 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$1.4M

How this compares

$0 in reported general payments places this provider in the 5th percentile of 334 infectious disease providers in New Jersey.

See all infectious disease providers in New Jersey

Medicare billing

Part B allowed, 2024
$134,463
Medicare patients
283
Services billed
1,232

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ErtapenemErtapenem Sodium12$2,875
CeftriaxoneCeftriaxone Sodium15$2,860
Vancomycin Hcl14$2,288
Cefepime Hcl12$1,550
Methenamine Hippurate12$1,084
Cefazolin Sodium18$633

Paid to pharmacies, not to this prescriber.

Other infectious disease in Flemington

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →